L. Chin, L. A. Garraway, and D. E. Fisher, Malignant melanoma: genetics and therapeutics in the genomic era, Genes & Development, vol.20, issue.16, pp.2149-82, 2006.
DOI : 10.1101/gad.1437206

H. F. Weber, T. L. Seigler, H. Darrow, R. Paterson, C. J. Marais et al., Mutations of the BRAF gene in human cancer, Nature, vol.417, pp.949-54, 2002.

V. Delmas, F. Beermann, S. Martinozzi, S. Carreira, J. Ackermann et al., beta-Catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development, Genes & Development, vol.21, issue.22, pp.2923-2958, 2007.
DOI : 10.1101/gad.450107

V. C. Gray-schopfer, S. C. Cheong, H. Chong, J. Chow, T. Moss et al., Cellular senescence in naevi and immortalisation in melanoma: a role for p16?, British Journal of Cancer, vol.187, issue.4, pp.496-505, 2006.
DOI : 10.1038/sj.bjc.6603283

L. Larue and V. Delmas, The WNT/Beta-catenin pathway in melanoma, Frontiers in Bioscience, vol.11, issue.1, pp.733-775, 2006.
DOI : 10.2741/1831

E. V. Sviderskaya, V. C. Gray-schopfer, S. P. Hill, N. P. Smit, T. J. Evans-whipp et al., p16/Cyclin-Dependent Kinase Inhibitor 2A Deficiency in Human Melanocyte Senescence, Apoptosis, and Immortalization: Possible Implications for Melanoma Progression, JNCI Journal of the National Cancer Institute, vol.95, issue.10, pp.723-755, 2003.
DOI : 10.1093/jnci/95.10.723